Short Interest in Alpha Tau Medical Ltd. (NASDAQ:DRTS) Rises By 7.1%

Alpha Tau Medical Ltd. (NASDAQ:DRTS) saw a significant growth in short interest in December. As of December 31st, there was short interest totalling 72,600 shares, a growth of 7.1% from the December 15th total of 67,800 shares. Based on an average trading volume of 45,600 shares, the short-interest ratio is presently 1.6 days. Approximately 0.1% of the shares of the stock are short sold.

Wall Street Analyst Weigh In

Separately, HC Wainwright restated a “buy” rating and issued a $9.00 target price on shares of Alpha Tau Medical in a research report on Friday, November 22nd.

Alpha Tau Medical Stock Performance

NASDAQ DRTS traded up $0.01 during trading on Friday, hitting $3.91. 92,315 shares of the company’s stock traded hands, compared to its average volume of 51,170. The stock has a fifty day moving average of $2.99 and a two-hundred day moving average of $2.50. Alpha Tau Medical has a 12-month low of $1.75 and a 12-month high of $4.08.

Alpha Tau Medical Company Profile

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others.